AstraZeneca’s Dapagliflozin tablets get DCGI nod for chronic kidney disease
AstraZeneca Pharma India on Saturday mentioned it has received approval from the Medicines Controller Common of India (DCGI) for Dapagliflozin…
Change Your Business
AstraZeneca Pharma India on Saturday mentioned it has received approval from the Medicines Controller Common of India (DCGI) for Dapagliflozin…
Paving way for well timed roll out of a further indigenous Covid-19 vaccine, the Medication Controller Common of India (DCGI)…
WhatsApp us